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ABSTRACT 
Nanotechnology is having a high impact on the development of a novel class of biosensors called nanobiosensors. This technology has utilized some 
extremely exciting elements for sensing phenomenon improvement. The utilization of nano-materials, nano-rods, nano-particles, nano-tubes have 
aided rapid, reliable reproducibility and its detection in a much better way. The unique properties of nanobiosensors and its varied applications 
have influenced biosensing research. Since longtime, nanobiosensors have been utilized worldwide for the diagnosis of diseases co-related with 
molecular detection of biomarkers. This paper highlights the use of such nanobiosensors for the detection of the virus, infections, fungal pathogens, 
Human Immunodeficiency Virus (HIV) related diseases such as Cardiovascular diseases (CDVs), Renal Arthritis (RA) through different techniques 
including electrochemical biosensing, optical biosensing, point of care-diagnostics etc.  
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INTRODUCTION 
Viruses are the tiniest parasites which have the capability in 
affecting the physiological behaviour of the host in which they enter 
and infect. Several living species such as bacteria, plants, human 
beings and animals are the host of these viruses. Viruses are 
adaptable and their modes of action are varied; due to this greater 
number of deaths are occurring in the entire globe, especially 
because of the human immunodeficiency virus (HIV), Zika virus 
(ZIKs), influenza infections etc. The transmutation of the existing 
known viruses currently leads to epidemics, most probably when 
such mutation occurs at the single level of nucleic acid it may be fatal 
for the human population. Thus, early diagnosis of these viruses is of 
high importance for improving the patient’s quality of life. Varied 
conventional approaches are available for the detection of viruses 
and their interaction in developing infections [1]. Biosensors and 
nano-bio sensors are one of the conventional methods for the 
detection of such viruses. Since a long time, the use of biosensors has 
been one of the fastest technologies due to its varied applications. A 
biosensor is defined as a device which is designed for detection and 
quantification of a biochemical molecule for example DNA sequence, 
antibodies, enzymes, immunological molecules or proteins. 
Biosensor device consists of three components viz; bioreceptor 
(analyzes the material), transducer (converts signal) and detector 
(gives response). Later, nanotechnology showed exciting ingredients 
for the improvement of the biosensing phenomenon, this technology 
developed a novel class of biosensors named as nano-biosensors. 
The high sensitivity of nano-bio sensors is one of the potential 
benefits for its detection over conventional methods [2]. 
Nanobiosensors are defined as the devices that are used for 
measurement of a biological or biochemical event by using any 
magnetic, optical or electronic technology through a compact probe. 
Due to the utilization of several nanomaterials such as nanoparticles, 
nanorods, nanotubes and nanowires this device enables faster 
detection and its reproducibility in a better way. High surface area 
nanomaterials are useful in producing nano-bio sensors with shorter 
response times and greater sensitivity. Selenium nanoparticles 
(SeNPs) are also being used for various therapeutic applications 
such as antioxidant, anticancer and antimicrobial etc [3]. The 
nanostructures present in nano-biosensors act as an intermediate 
layer in between physicochemical detector components and 
biological agents, with nanomaterials a transducer is combined to 
construct a biosensor. Nanobiosensors are classified in a varied 
diverse area for their sensing mechanism, such as optical, 
electrochemical, mechanical and calorimetric. Fig. 1 depicts the 
different variations and types of nanobiosensors. A nanobiosensor is 
majorly used to detect several biological agents, such as nucleic 
acids, pathogens, antibodies and metabolites. Nanobiosensors has 
varied applications ranging from the estimation and diagnosis in the 
in vivo aspects of the healthcare industry, environmentally 
monitoring toxicants, pollutants and physical aspects like heavy 
metal toxicity, humidity, etc. Recently in one of the articles it is 
revealed that nanovaccines and nanobots are also under 
consideration for the treatment of most of the diseases [4]. 
Considering the advantages of these nanobiosensors, in current 
review, we will summarize different types of nanobiosensors 
developed so far for the detection of viral diseases [5]. 
 
 
Fig. 1: Nanobiosensors types and variations 
 
Search criteria 
The selection of articles for the current review were searched by using 
keywords in certain specialized databases such as Elsevier (Science 
direct), Pubmed Medical subject headings (MeSH) and Medline. The 
keywords which were utilized are terms that were related to 
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nanobiosensors and its diseases such as; “Nanobiosensors used for 
detection of viral diseases” OR “Viruses detected through 
nanobiosensors”. Articles displayed on specialized databases were 
screened manually on basis of their title and abstract. Irrelevant and 
duplicate documents were excluded and those articles that met the 
inclusion and exclusion criteria were included in this study. Inclusion of 
these studies was based on the following criteria: (a) in a peer-reviewed 
journal it should be an original publication; (b) nanobiosensors should 
be utilized for the detection of diseases related to viruses. Only those 
articles which were written in English and published till now i. e; 2020 
were reviewed. Exclusion criteria, were articles which are not applied to 
pharmaceutical field and those articles which were written in any 
language other than English, duplicates etc. After filtration and screening, 
52 studies published between 1996-2020 met the inclusion criteria and 
these were included in the review. The selection strategy of review 
articles which were included is portrayed in the flow chart (fig. 2). 
  
 
Fig. 2: Flow chart of the selection strategy of articles included in the review 
 
Overview of electrochemical nanobiosensors 
Biosensors based on nanomaterials have been utilized for the 
detection of biological molecules in the entire world. It is an evolving 
field where the interrogation of the electrochemical nanobiosensors 
is utilized in the form of impedance, current and potential. When 
there a is change in the signal response, the biological recognition 
event with high sensitivity and selectivity occurs. This type of 
biosensors is also utilized for the detection of glucose and are used 
with the combination of varied analytical techniques with their 
specificity of the desired analyte, such as conductometry, 
potentiometry, voltammetry etc. Due to the rapid detection and 
outstanding results through nanobiosensors these are used 
worldwide for detection of virus in disease diagnosis compared to 
conventional methods, such as RT-PCR, ELISA which are expensive 
and require more time [6]. Table 1 gives a glimpse of detection 
values, linearity range, nanomaterials used and detection method by 
Electrochemical nanobiosensors for diagnosis of diseases. 
 
Table 1: Overview of electrochemical nanobiosensors in viral diseases 
Detection method Nanomaterial Limit of detection Linear range References 
EIS Indium tin oxide electrodes 2-3 ng/ml 1-1000 ng/ml [7] 
glip-T 1,6-Hexanedithiol and chitosan 
stabilized gold nanoparticle 
0.32±0.01 x10-[14] 1x10-[14]-1x10-2 M [8] 
DNA hybridization Electrospun semi-conducting 
Manganese (III) Oxide (Mn2O3) 
120 x 10-[21] M - [9] 
SWCNTs Nanotubes 102 CFU/ml 102-10[10] CFU/ml [10] 
EIS Mercaptopropylphosphonic acid 
functionalized copper doped zinc oxide 
nanofibers 
6 ag/ml 10 ag/ml-10 µg/ml [11] 
Amperometry Silver graphene quantum dots 
(Ag/GQDs) 
1ZM 1µM to 1ZM [12] 




5’ aminated DNA probes 9.55 x 10-[12]M 10-[12] to 10-6 M [14] 
EIS-Electrochemical impedance spectroscopy, SWCNTs-single-walled carbon nanotubes, CFU-colony forming unit, ag-attogram, µg-microgram, ZM-
zepto molar, µM-micro-molar 
 
Electrochemical methods 
Electrochemical nanobiosensors are the most common biosensors 
widely developed and utilized due to its several applications in 
agricultural, and especially in clinical applications and for industrial 
analysis. These biosensors generally provide several advantages 
ranging from high specificity of their biological recognition process, 
better specificity, low background noise, cost-effectiveness, rapid 
detection and better signal-to-noise ratio. Due to these varied 
applications and advantages, Electrochemical nanosensors are utilized 
for early detection of disease-related biomarkers [15]. Lin et al. (2018) 
designed a 3D nanostructured indium-tin-oxide (ITO) electrodes, 
immobilized it with toll-like receptor proteins (TLRs) for detection of 
the microbial pathogen components. Results revealed a linear dynamic 
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range of (>104) and magnitude lower detection limits of (2-3 ng/ml of 
the microbial component) with 30 times better sensitivity for 
lipopolysaccharide and flagellin when compared with planar gold and 
ITO-based TLR sensors using TLR-based Electrochemical impedance 
spectroscopy (EIS) biosensors [7]. Bhatnagar et al., (2018) developed 
1,6-Hexanedithiol and chitosan stabilized gold nanoparticle-mediated 
self-assembly of glip probes (glip-P) on gold electrode-based 
electrochemical biosensor for diagnosis of Invasive Aspergillosis, which 
is caused by Aspergillus fumigatus. The limit of detection of this 
biosensor was calculated to be as 0.32±0.01 x10-14 (RSD<5.2 %) within 
a dynamic range of 1x10-14-1x10-2 M. [8] In another study, Tripathy et 
al., (2017) have detected dengue virus through nanofibres of 
Electrospun semi-conducting Manganese (III) Oxide (Mn2O3) based 
Electrochemical DNA nanobiosensor. The limit of detection was reported 
to be 120 x 10-21 M [9]. Yoo et al., (2017) developed a single-walled 
carbon nanotubes (SWCNTs)-based electrochemical nanobiosensor to 
detect microorganisms found in Asian dust events which is Bacillus 
subtilis. SWCNTs revealed a reliable and sensitive detection with a 
detection limit of 102 CFU/ml and a linear range of 102-1010 CFU/ml 
within 10 min of detection time [10]. Brince Paul et al., (2016) designed 
Mercaptopropylphosphonic acid functionalized copper doped zinc oxide 
nanofibers and synthesized these nanofibers through electrospinning 
technique to detect Plasmodium falcipuram histidine-rich protein-2. The 
biosensing showed detection limit of 6 attogram/ml, and detection range 
of 10 ag/ml-10 µg/ml with excellent sensitivity 28.5 KΩ/(gm/ml)/cm2 
[11] Electrochemical nanobiosensors are also widely utilized for the 
detection of cancer [16]. 
Amperometric methods 
Amperometric nanobiosensors have the ability to measure the 
current which is produced for determining the quantity of an analyte 
with fixed potential and measure the current through 
electrochemical oxidation or reduction at the working electrode. 
Recently the use of this biosensors is becoming more common [17]. 
In this study, Mobed et al. developed a novel paper-based genoassay 
for monitoring L. penumophila. Silver graphene quantum dots 
(Ag/GQDs) the ink was utilized for bioassay of L. penumophila. The 
quantification and detection limit of this platform was 1ZM and 
linear range of cDNA was 1µM to 1ZM via using chronoamperometry 
technique and results revealed that despite a simple structure L. 
penumophila has high sensitivity and specificity for the DNA based 
bioassay [12].  
Voltammetric methods 
Voltammetric nanobiosensors are most commonly used and 
available methods for ultrasensitive detection of various pathogens 
because of their high sensitivity, the ability of simultaneous 
quantification of targets, selectivity and cost-effectiveness. These 
nanobiosensors includes different methods such as linear sweep 
voltammetry (LSV), square wave voltammetry (SWV), differential 
pulse voltammetry (DPV) and cyclic voltammetry (CV). Nguyen et 
al., (2009) and colleagues have developed an electrochemical 
nanobiosensor based on membrane for sensing of inactivated West 
nile viral particle and West nile virus protein domain III (WNV-DIII) 
by utilizing anti-WNV-DIII immunoglobulin M (IgM) as the 
biorecognition probe. The detection limit of this platform was 4 pg 
ml-1 via using voltametric detection method and high sensitivity 
was achieved [13]. 
Membrane-based sensors 
Nanobiosensors based on membrane sensors is utilized worldwide 
in several biomedical applications. Because of the nature of 
nanospores, these are used as filters for the isolation of DNA, cells, 
RNA, bacteria, viruses and proteins detection. They have regular and 
uniform spaced nanochannels, which act as templates for the 
incorporation of nanosized materials ranging from metals, 
semiconductors, polymers, metals, and biomolecules which impart 
the novel biological and physicochemical characteristics to enhance 
the applications of membrane-based sensors. Membrane-based 
nanobiosensors have uniform size nanopores, high surface area, 
cost-effective, high aspect ratio and are easy to prepare [18]. Rai et 
al., (2012) designed ultrasensitive nanoporous membrane-based 
DNA biosensors using 5’ aminated DNA probes and immobilized it 
on the alumina channel walls to detect the dengue virus (DENV). The 
detection limit of detection of this nanobiosensor was 9.55 x 10-12 
M with a linear range of over 6 order of magnitude i.e., 10-12 to 10-6 
M and high specificity [14]. 
Overview of optical nanobiosensors 
Optical nanobiosensors are used widely due to its varied advantages 
over conventional techniques, which include high sensitivity, 
specificity, small size and less cost. Optical nanobiosensors are 
utilized in several fields, mainly healthcare, biotechnology, 
environment industry. Recently, the monitoring and diagnosis of 
varied diseases have undergone risky variations via optical 
biosensors. Fluorescence nanobiosensors are one of the most 
common optical methods used for detection of several 
pathogens/viruses because of their label-free detection capability, 
specificity, sensitivity, and cost-effectiveness [19]. Table 2 gives a 
glimpse of detection values, linearity range, nanomaterials used and 
detection method by optical nanobiosensors for diagnosis of 
diseases.
  
Table 2: Overview of optical nanobiosensors in viral diseases 
Detection method Nanomaterial Limit of detection Linear range References 
Fluorescence CdTe QDs  0.13 µg ml-1 - [20] 
Fluorescence Oligonucleotide probes labeled with 
quantum dots and (AuNPs-Rh) 
3x10-8 M - [21] 
Fluorescence CdTe QDs 0.2 nM 1.0 to 50.0 nM [22] 
Fluorescence Nanobeads 102-103 CFU/ml 0-0.2 µM [23] 
SPRi AuNPs induced with QDs 0.03 pg/ml and 0.4 pg/ml, 10 PFU/ml - [24] 
Fluorescence SiO2-encapsulated alloyed CdZnSeS QDs 8.2 copies/ml and 9.3 copies/ml - [25] 
Fluorescence FAIA 220 pg/ml 400 pg/ml to 25 ng/ml [26] 
Microfluidic device SERS 0.01 IU/ml 0.0125-60 IU/ml [27] 
Microfluidic chip RT-LAMP 1 copy/µl - [28] 
AuNPs-Rh-rhodamine-immobilized gold nanoparticles, CdTe QDs-Cadmium-telluride quantum dots, CFU-colony forming unit, AuNPs-gold 
nanoparticles, FAIA-fluorescent anisotropic immunoassay, SERS-surface-enhanced Raman scattering, IU= international unit, RT-LAMP-reverse-
transcription loop-mediated isothermal amplification. 
 
Gold nanoparticles 
Over the past few decades, Gold nanoparticles (AuNPs) have been 
the subject of interest for research in biomedicine. AuNPs is also 
known as colloidal gold have novel diagnostic purposes or optical 
properties due to which it became popular worldwide in recent 
years for its applications in medicine. Nowadays, these AuNPs are 
utilized in the entire globe as point-of-care tests and novel testing 
strategies since it provides more sensitive, simpler, faster and cost-
effective assays to clinical laboratories [29]. In a study by Razmi et 
al., (2019) Tomato yellow leaf curl virus (TYLCV) genome in plants 
which are infected was detected using unmodified AuNPs and 
eliminated the need for detection equipment/PCR amplification 
[30]. Wang et al., (2017) utilized simple colorimetric detection 
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method; for this he developed unmodified gold nanoparticles as 
colorimetric probes and detected Cucumber green mottle mosaic 
virus (CGMMV), which is transmitted by infected cucumber seeds, 
leaves and soil [31]. Shawky et al., (2010) also utilized colorimetric 
assay by developing unmodified AuNPs for direct detection of 
unamplified Hepatitis C virus (HCV) RNA, this assay was capable of 
detecting 50 HCV copies/reaction [32]. Baetsen-Young et al., (2018) 
developed a novel unamplified genomic DNA (gDNA) nanosensor 
with the help of dextrin capped AuNPs to detect the causal agent of 
cucurbit downy mildew which is the unamplified DNA sequence 
from Pseudoperonospora cubensis, 2.94 fM of pathogen DNA was 
detected [33]. Kaushal et al., (2019) designed the nanobiosensor 
based on gold nanorods (AuNRs) for the detection of foodborne 
bacteria due to its good electro-optical properties [34]. 
Fluorescence 
Fluorescent nanomaterials are one of the promising approaches in 
optical nanobiosensors. These biosensors are also widely used as an 
alternative for conventional methods. In a recent study, Shokri et al., 
2020 has detected citrus Tristeza virus by fluorescence anisotropic 
immunoassay through targeting the virus protein, CP25 to emit 
copper nanoclusters. The detection limit with assay was reported as 
220 pg/ml within a linear range of 400 pg/ml to 25 ng/ml [26]. 
Similarly, Shojaei et al., (2016) reported a nanobiosensor based on 
fluorescence resonance-energy transfer (FRET) with the help of 
cadmium-telluride (CdTe) quantum dots (QDs) conjugated by a 
specific antibody against coat protein (CP) of CTV, and the CP were 
immobilized on the surface of gold nanoparticles (AuNPs) for 
determination of citrus Tristeza virus (CTV). The sensitive biosensor 
showed a detection limit of 0.13 µg ml-1 and 93%,94 % of 
sensitivity, specificity respectively over enzyme-linked 
immunosorbent assay (ELISA) [20]. Sabzehparvar et al., (2019) 
developed FRET-based technique nano biosensor for detecting VP2 
gene of infectious bursal disease virus utilizing two oligonucleotide 
probes labelled with quantum dots and rhodamine-immobilized 
gold nanoparticles (AuNPs-Rh) and the LOD value was estimated to 
be 3x10-8 M [21]. Shamsipur et al., (2017) also developed a 
nanobiosensor based on FRET by utilizing CdTe QDs, which is water-
soluble and detected Human Papillomavirus 18 (HPV18). Results 
showed the detection limit of 0.2 nM with an increase in DNA target 
concentration within the linearity range from 1.0 to 50.0 nM [22]. In a 
study by Xu et al., (2017), a fluorescence nanobiosensor was designed 
by combining it with nanobead-based immunomagnetic separation for 
detection of bacterial pathogens in food products viz; E. coli, L. 
monocytogenes, S. Typhimurium. The detection limit for these bacterial 
pathogens was found to be 102, 103, 103 CFU/ml in lettuce, ground 
beef and shrimp, respectively [23]. Adegoke et al., (2016) designed an 
ultrasensitive QD fluorophore and exploited it as fluorescence signal 
generator. Further, modified silanization method for encapsulation of 
the thiol-capped QDs in a silica layer was modified and alloyed 
thioglycolic (TGA)-capped CdZnSeS QDs with high photoluminescence 
(PL) quantum yield (QY) value of 92% were synthesized to detect the 
norovirus. The authors reported a detection limit of 8.2 copies/ml and 
9.3 copies/ml in human serum and buffered respectively. Also, 
sensitivity was increased to 3-fold in comparison to norovirus RNA 
using TGA-capped CdZnSeS QD-MBs [25]. 
SPR/SPRi 
AuNPs show a specialized phenomenon which is commonly called as 
Localized Surface Plasmon Resonance (LSPR) is responsible for 
intense red colour. SPR has a wide range of applications for 
diagnostic purposes; these nanobiosensors have become popular for 
its measurements in molecular interactions. An SPR biosensor was 
fabricated by Ming-Ju Chen, Kreuter et al., (1996) for the detection of 
insect pathogen-the baculovirus commonly called as Autographa 
californica multiple nuclear polyhedrosis virus (AcMNPV). Also, in 
another study, Boltovets et al., (2004) detected tobacco mosaic virus 
(TMV) through SPR technique [35, 36]. In another study, Takemura 
et al., (2017) developed a localized surface plasmon resonance 
induced immunofluorescence (SPRi) nano biosensor for detection of 
influenza virus H1N1 and H3N2. This biosensor was based on a gold 
nanoparticle-induced with quantum dot fluorescence signal. The 
LOD for H1N1 influenza virus was found to be 0.03 pg/ml and 0.4 
pg/ml in deionized water and human serum respectively, this 
showed high sensitivity. Whereas, H3N2 influenza virus which was 
clinically isolated reported the LOD value of 10 PFU/ml [24]. 
Waveguide mode biosensors 
Waveguide biosensors are similar to the working procedure of 
surface plasmon resonance biosensing. The only difference in these 
both is the way of conducting measurements, these biosensors 
conduct measurements through waveguide mode. Maldonado et al., 
(2016) designed a bimodal waveguide (BiMW) based-photonic 
interferometer biosensor to detect Escherichia coli and Bacillus 
cereus infections caused in cirrhotic patients [37]. 
Microfluidic devices 
Microfluidic devices are the new type of diagnostic methods which 
are sensitive, accurate, easy to use, and give rapid responses for 
dangerous viruses, including HBV, ZIKV, HIV and also in foodborne 
viruses. Microfluidic platforms depend upon the steps of 
miniaturization ranging from the preparation of the specimen to, 
bioreaction and further, it is detected into a unique system. The 
conventional techniques require much more time for the 
identification or detection of viruses, whereas these microfluidic 
devices consume less time for diagnosis and clinical treatment, 
which is vital for the patient’s survival. Owing to the nature of these 
microfluidic kits, these might be advantageous in the localities with 
poor health facilities [38, 39]. Huang et al., (2017) designed a 
microfluidic chip insulated with air and detected varied pathogens 
related to pneumonia. The pathogens which where been detected 
are Mycoplasma pneumoniae, Staphylococcus aureus, and methicillin-
resistant S. aureus. 99.56% coincidence rate was determined, which 
reveals that the correct results were reported [40]. Kamińska et al., 
(2015) developed surface-enhanced Raman scattering (SERS) an 
ultrasensitive immunoassay with a new Raman reporter and unique 
SERS-active substrate and incorporated this in a microfluidic device 
to detect hepatitis B virus (HBV). The detection limit obtained was 
0.01IU/ml and high specificity was obtained [27]. Kaarj et al., (2018) 
detected Zika virus through a wax-printed paper microfluidic chip. 
This microfluidic chip was developed using reverse-transcription 
loop-mediated isothermal amplification (RT-LAMP). This platform 
showed the detection limit of 1 copy/µl and also proved that this 
technique can also be utilized for the identification of other 
flaviviruses, including dengue virus, chikungunya virus, also other 
viral pathogens that are quickly transmitted towards field-based 
diagnostics [28]. Dao et al., (2018) designed a new nanobiosensor 
based on isothermal amplification, which combines microfluidic 
enrichment by utilizing a concanavalin which is a functionalized 
microchannel consisting of asymmetric herringbone groove arrays. 
These nanobiosensors are utilized for rapid detection of pathogens so, 
with the help of this nanobiosensor Dao and his coworker’s detected 
Salmonella enterica serotype Typhimurium bacteria which causes 
urinary tract infections. Due to the utilization of microfluidic 
enrichment the sensitivity increased by 1.76 orders of magnitude [41].  
Point of care testing (POCT) 
POCT is the cheap and effective medical diagnostic technique which 
are been utilized for the detection of varied infections or diseases 
caused through viruses such as, hepatitis, HIV and Influenza. POCT 
techniques are also used by patients at their bedside, which are 
classified into the following two types: the benchtop or the handled 
devices, which include HIV detection from salivary assay and 
checking of glucose levels. Some of the POC testings are based upon 
paper techniques which were applicable for the detection of viruses. 
This paper-based diagnosis is easy to use, inexpensive, and 
disposable, which makes it well adaptable technique. Over the 
course of time, for the detection of colorimetric substances, paper-
based sensors were replaced through different methods, including 
fluorometric, chromatographic, electrochemical, microfluidics etc 
[42]. Zhang et al. and his co-workers designed a simple and effective 
detection method for infectious disease using quantum dots 
nanobeads (QDNBs) as the amplified signal indicators. This proved 
the detection of hepatitis B surface antigen (HBsAg) proteins and 
also improved the sensitivity of dot-blot immunoassay detection 
through amplification of fluorescent signals with quantum dot 
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nanobeads [43]. Darbha et al. demonstrated that the HIV-1 viral DNA 
sequence can be screened by utilizing gold nanorods. The hyper-
Rayleigh scattering (HRS) proved the efficient detection of HIV-1 
virus DNA with an increase in intensity, sensitivity (100 picomolar) 
and selectivity [44]. Griffin et al. also utilized the HRS technique with 
gold nanoparticles for the detection of hepatitis C virus (HCV). The 
gold nanoparticles were conjugated with HCV ssRNA tagged along 
with rhodamine 6G. HCV ssRNA was detected and the selectivity 
reached a mismatch of single-base pair [45]. Chung et al., designed a 
nanoparticle system with a dual probe which was capable of 
phenotyping and detecting human pathogens. An assay of 
nanoparticle was designed specifically based on a sandwich 
hybridization technique which involved two probes of 
oligonucleotides to target the bacterial 16S rRNAs for the detection 
of amplified targeted DNAs through the utilization of a miniaturized 
NMR device. The magneto-DNA platform was found, which allowed 
universal and specific detection of varied clinically relevant bacterial 
species, with sensitivity down to relevant bacteria. Further, they 
found the assay to be robust and rapid and simultaneously 
diagnosed a panel of 13 bacterial species in the clinical specimen 
within the time limit of 2 h; also, a generic platform was formed for 
rapid identification of phenotype pathogens due to the varied 
applications [46]. In another study, Lee et al., and his colleagues 
developed a handheld diagnostic magnetic resonance (DMR) system 
for fast analysis using magnetic-nanoparticles as a proximity sensor 
for magnification of molecular interactions. It was found that DMR 
system is able to perform the measurements on biological samples 
which are unprocessed and can also be utilized for the 
characterization and detection of infectious agents ranging from 
bacteria, fungi, viruses etc. Later, they predicted that this DMR 
system when combined with the strategies of microfabrication it 
might be utilized as a portable, affordable, high-throughput POC 
nano diagnostics system for detection of significant infectious 
diseases in the future [47]. In yet another study by Liong et al., 
magnetic-nanoprobes have been utilized to develop the strategy of 
magnetic barcoding for the detection of Mycobacterium tuberculosis 
(MTB). PCR-amplified mycobacterial genes were captured on 
microspheres sequence-specifically, labelled by magnetic 
nanoprobes and were detected by NMR. The components were 
integrated into a fluidic cartridge for streamlined chip-operation, 
this platform was utilized for the detection of M. tuberculosis and for 
the identification of drug-resistant strains within 2.5 h from 
mechanically processed sputum samples. From the measurements of 
MTB-positive patient specimens, the clinical utility was 
demonstrated and the confirmation for the assay specificity was 
done clinically by non-MTB bacteria. Results demonstrated that a 
combination of magnetic barcode assay system with portable 
systems might be potential for becoming a sensitive, low-price and 
high throughput platform for infectious diseases point of care-
diagnostics [48]. Cihalova et al., also utilized magnetic barcode as a 
point of care diagnostics for the detection of most infectious fungal 
pathogens viz; Klebsiella pneumoniae, Staphylococcus aureus, 
methicillin-resistant Staphylococcus aureus and bacteria using 
fluorescent nanoparticle quantum dots (QDs). The results concluded 
that the method had the capability for the detection of infectious 
bacteria as low as the concentrations of 102 CFU/ml [49]. In a study 
by Inci et al., a unique nanoplasmic-based sensor was developed for 
the detection of HIV at different concentrations by using 
immobilized antibodies for capturing rapidly evolving viral subtypes 
selectively. Results demonstrated that detection of data analysis 
took 10 min and exhibited high sensitivity, specificity and 
repeatability of 98±39 copies/ml. It also specified that the viral 
diseases detection directly from unprocessed blood samples of 
patients were feasible, showed a significant step towards POC tests 
at resource-constrained settings, hospitals etc. by enabling rapid 
detection, isolation, quantification and capture of viruses [50]. 
Kosaka et al. and his co-workers designed an immunoassay by the 
combination of both nano-mechanical properties of gold nano-
particles and opto-plasmonic transduction methods. By this 
immunoassay HIV-1, capsid antigen p24 in the human serum was 
detected. The limit of detection was reported to be 10-17 g/ml. and 
it was proved that this technology meets the demands to be 
produced en masse at a much lower cost, the capability for the 
miniaturization can be used as a point of care tests and also proved 
this platform to be an easily adaptive technique for diagnosis 
compared to Nucleic acid amplification tests (NAAT) [51]. Islam et 
al. developed a smart nanosensor utilizing graphene-based field 
effective transistors and detected HIV-related diseases, including 
renal arthritis (RA) and cardiovascular diseases (CVDs). Graphene 
was functionalized with aminoalkanes and was conjugated 
covalently with varied antibodies such as anti-p24 for HIV, anti-
cyclic citrullinated peptide (anti-CCP) for RA and anticardiac 
troponin 1 (anti-cTn1) for CVDs via carbodiimide activation for 
detection of various biomarkers. Results concluded that high 
sensitivity with good linear curve was exhibited, the limit of 
detection for various antibodies were reported to be 10fg/ml for 
cTn1 and CCP and 100fg/ml for p24. Further, they concluded that 
the nanobiosensor based on graphene confirmed excellent 
performance and can be utilized for the on-site detection of HIV, 
Rheumatoid Arthritis and Cardiovascular diseases biomarkers in 
real samples [52]. Ng et al., proved the extensive utilization of POC 
system to detect HIV in saliva, leukocytosis in whole blood and 
plasma by utilizing mobile-based magneto-nano sensor arrays and 
magnetic nano-particles. This utilization of mobile-based magneto 
nano sensor device proved the ability to detect HIV in saliva and 
leukocytes in plasma quantitatively at a point of care within the 
assay time of 16 min with an accuracy of 90%, 80% respectively. 
Thus, they concluded that the portability, high sensitivity and ease of 
use of their nanodevice has the potential for becoming a low-cost 
and high throughput platform for point of care-diagnosis of HIV and 
early detection of diseases [53]. 
Nucleic acids-and protein-based nanobiosensors 
Recently a newly based technique of nucleic acids-and protein-based 
nanobiosensors has been developed for detection of the novel 
emerging COVID-19 virus. The high specificity, selectivity and rapid 
biosensing activity of nanobiosensors have made it useful for the 
detection of specific proteins or nucleic acids of COVID-19.  
Immunoglobulin (Ig)-based nanobiosenors 
Immunoglobulin (Ig)-based nanobiosensors have also been utilized 
for the detection of newly emerging COVID-19 virus since our 
system can produce Ig in the face of COVID-19 utilizing 
nanobiosensor-based serological tests to determine specific 
antibodies which might be helpful.  
Sharifi et al., recently showed these two reported diagnostic 
methods viz; nucleic acids-and protein-based nanobiosensors and 
Immunoglobulin (Ig)-based nanobiosensors for the detection of 
COVID-19 virus [54]. 
Conclusion and future prospects 
Nanotechnology has significantly increased its demand in the 
development of biosensors and, has been proved useful for the 
detection of pathogens/viruses. Generally, the transduction 
mechanisms of these nanobiosensors have improved significantly 
due to the utilization of various nanoparticles for immobilization of 
enzymes, nanomaterials and nanostructures like those of quantum 
dots and hybrid nanostructures with varied functionalities. Unique 
advantages of these nanobiosensors over the assays of traditional 
methods such as low-price and high throughput platform, high 
sensitivity, specificity, rapid, reliable and real-time detection have 
made these nanobiosensors suitable for the detection of varied 
viruses. The use of nanobiosensors for POC testing has also 
enhanced sensitivity and became an appropriate signal amplification 
method. Some of the nanobiosensors have reached the limit of 
detection value in the picomolar and femtomolar range, due to 
which innovative strategies in the diagnosis of early-stage viruses is 
been provided in vivo and in vitro. However, the nanomaterials 
(NMs) biosafety must be observed in the utilization of nano 
biosensors for in vivo virus detection. Additionally, further efforts 
are required for the development of a nanosensing platform for 
detection of different virus-related diseases in vivo because most of 
the nanobiosensors have been employed for in vitro quantification. 
The more advancement and remarkable progress in the nanosensing 
platform with potential diagnostic features are expected to occur in 
future. 
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Table 3: List of abbreviations 
HIV Human immunodeficiency virus 
ZIKs Zika virus 
DNA Deoxyribonucleic acid 
RT-PCR Reverse transcription polymerase chain reaction 
ELISA Enzyme-linked Immunosorbent assay 
TLRs Toll-like receptor proteins 
DENV Dengue virus 
QDs Quantum dots 
AuNPs Gold nanoparticles 
LOD Limit of Detection 
FRET Fluorescence resonance-energy transfer 
SPR Surface Plasmon Resonance 
SPRi Surface plasmon resonance induced immunofluorescence 
SERS Surface-enhanced Raman scattering 
POCT Point of care testing 
QDNBs Quantum dots nanobeads 
HBsAg Hepatitis B surface antigen 
HRS Hyper-Rayleigh scattering 
DMR Diagnostic magnetic resonance 
NAAT Nucleic acid amplification tests 
NMs Nanomaterials 
CVDs Cardiovascular diseases 
RA Renal Arthritis 
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